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The performance of Etest KPC and MBL strips (bioMérieux) was evaluated as compared to other phenotypic
tests for detecting carbapenemases of the KPC-type and metallo-β-lactamases, respectively, on 133 well-
characterized enterobacterial isolates. KPC and meropenem-containing MP/MPI Etest had high sensitivity
(N92 %) and speciﬁcity (N97 %).
The rapid spread of carbapenemase-producing Enterobacteriaceae
(CPE) is a worldwide major challenge for the treatment and control of
many nosocomial and now community-acquired infections (Nord-
mann et al., 2011). These isolates produce different types of
carbapenemases, the most frequent being Klebsiella pneumoniae
carbapenemases (KPC; Ambler class A), metallo-β-lactamases (MBL;
Ambler class B, metallo-enzymes), and oxacillinases (OXA-48-type;
Ambler class D) (Ambler et al., 1991). KPC-type enzymes hydrolyze all
β-lactams including carbapenems, and are inhibited by aminophenyl
boronic acid (APBA) (Poirel et al., 2007). MBLs hydrolyze all β-
lactams, except aztreonam and are inhibited by divalent cation
chelators such as EDTA or dipicolinic acid (DPA).
MBLs and KPC detection by simple and reliable phenotypic tests is
needed for infection control and prevention (Giske et al., 2011;
Landman et al., 2005; Liao et al., 2011). Nevertheless, isolates
expressing these enzymes may be reported as susceptible to
carbapenems due to heterogeneous and variable levels of expression
of β-lactam resistance. The modiﬁed Hodge test (MHT) is usually
considered as the phenotypic reference method for conﬁrmation of
carbapenemase production despite the lack of discrimination be-
tween the three different classes of carbapenemases (KPC, MBL and
OXA) and difﬁculties in interpretation of the results. Commercial
diagnostic tablets from Rosco (RDS) (Rosco Diagnostica Neo-Sensi-
tabs, Eurobio, Courtaboeuf, France) consist in meropenem disks
supplemented with class A (APBA) or class B (DPA) β-lactamase
inhibitors. In this study, a prototype of Etest® KPC (bioMérieux, La
Balme-les-Grottes, France), containing meropenem and boronic acid,
and two commercially available Etest® MBL strips (bioMérieux, la
Balme-les-Grottes, France), IP/IPI, containing imipenem and EDTA and
MP/MPI, containing meropenem and EDTA, were compared to the
MHT, zinc-supplemented-MHT (Girlich et al., 2012), the RDS, and the
Carba NP test (rapid detection of any carbapenemase activity)
(Nordmann et al., 2012) for detecting KPC or MBL-producing
Enterobacteriaceae.
One-hundred thirty-three Enterobacteriaceae isolates, character-
ized at the molecular level, were used in this study. Forty-eight
Enterobacteriaceae isolates produced KPC-type β-lactamases, and 54
produced MBLs of the VIM- (n = 19), IMP- (n = 18), and NDM-type
(n = 17). Thirty-one non-carbapenemase producers (non CPE) were
used as controls, including nineteen isolates with decreased suscep-
tibility to ertapenem (Jacoby et al., 2004) and 12 carbapenem-
susceptible isolates. Strains were as follows: K. pneumoniae (n = 75),
Escherichia coli (n = 23), Enterobacter cloacae (n = 21), E. aerogenes
(n = 1), Serratia marcescens (n = 6), Citrobacter freundii (n = 4),
Proteus spp. (n = 2), and Salmonella typhimurium (n = 1).
Etest® MBL strips IP/IPI containing imipenem (4–256 μg/mL)/
imipenem (1–64 μg/mL) + EDTA (constant level), and MP/MPI
containing meropenem (0.125–8 μg/mL)/meropenem (0.032–2 μg/
mL) + EDTA (constant level), were used for detection of MBL-
producer, whereas Etest® KPC strips MP/MPB containing meropenem
(0.25–16 μg/mL)/meropenem (0.064–4 μg/mL) + a boronic acid
derivative (constant level) were used for detection of KPC-producers.
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Etest assays were performed as recommended by the manufacturer
(bioMérieux). MIC was read on each side of the strip. A N3-fold
decrease of the carbapenemMIC in the presence of the inhibitor or the
presence of a deformed ellipse on the IPI, MPI or MPB side of the strip
were interpreted as a positive test for MBL and KPC, respectively. All
other cases were considered as negative or non-determinable (ND), i.e.,
withMICs over or below the limit detection values of the strips (N16/N4
or b4/b1). KPC Etest strips showed a high sensitivity of 91.7% and a
speciﬁcity of 90.3% (Table 1). For detection of MBL producers,
meropenem containing strips were more efﬁcient than those contain-
ing imipenem, with a respective sensitivity of 94.4% and 81.5%
(Table 1). Among the MBL producers, all NDM- and VIM-producers
were detected with meropenem-containing Etest MBL, whereas IMP-
producers were detected at 82% (Table 1). Noticeably, a great disparity
in MIC values of imipenem was observed between single IP strips and
double IP/IPI strips (data not shown). As recommended by the
manufacturer, the MBL IP/IPI Etest should not be used for determining
MIC values, but only for comparison of MIC values with and without
EDTA (on each part of the strip). Indeed, among MBL producers, ten
strains gave non-determinable results with MIC values of IP b4 μg/mL
and IPI b1 μg/mL, and 44 strains gave a positive result, mostly because
of the modiﬁcation of the shape of inhibition ellipse in the presence of
EDTA. The three formulations of Etest, showed a high speciﬁcity
ranging from 97–100% (Table 1).
The Modiﬁed Hodge Test (MHT) was performed on MHA as
recommended (Clinical & Laboratory Standards Institute, CLSI, 2012),
and zinc-modiﬁed-MHT (MHT-Zn) with a supplementation with zinc
sulfate (100 μg/mL) (Girlich et al., 2012). Sensitivity of the MHT was
91.8% for detection of carbapenemase producers of both Ambler
classes, including a sensitivity of 100 % for detection of KPC producers,
and 85% for detection of MBL producers. Addition of zinc sulfate
increased the sensitivity from 91.8–95.1%, improving detection of
MBL producers in particularly of NDM-1 producers from 85–92.6%
(Table 1). A Concomitant decreased speciﬁcity was observed, from
90.3–83.9% (Table 1), accordingly to results of a previous study
(Girlich et al., 2012).
The RDS KPC and MBL conﬁrm kit consisting in four tablets
containing meropenem, meropenem + boronic acid, meropenem +
dipicolinic acid, and meropenem + cloxacillin was used following the
instructions of the manufacturer and results were interpreted as
recommended (Rosco Diagnostica). Sensitivity of the RDS was 94.1%,
comprising a sensitivity of 96% for detection of class A carbapenemase
producers and 92% for detection of class B carbapenemase producers
(Table 1). Noticeably, among MBL producers, all NDM- and VIM-
producerswere efﬁciently detectedwith the RDS. Speciﬁcity of RDSwas
96.7%, with only one isolate with reduced susceptibility to carbapenems
detected as MBL-producer, probably due to a non speciﬁc effect of DPA.
The recently developed Carba NP test, based on the rapid detection
of the hydrolysis of imipenem by a change in the pH value of the
indicator (red to yellow/orange) was used as previously described
(Nordmann et al., 2012). Sensitivity and speciﬁcity of the Carba NP
test was 100% on the tested strains (Table 1).
The main advantage of the MBL and KPC Etests (and the RDS) over
the MHT and the Carba NP test is the rapid discrimination between
class A and class B carbapenemase producers. However, the Carba
NP test II, which includes inhibition by tazobactam and EDTA, may be
also used for detection of carbapenemase types (Dortet et al., 2012).
One limitation of this study is that class A carbapenemase producers
from other types than KPC have not been studied. Indeed, boronic
acid contained in KPC Etest would be likely also a good inhibitor
of other Ambler class A carbapenemases such as GES-types, NmcA,
and Sme-1.
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Table 1
Comparison of MHT, zinc-supplemented MHT (Zn-MHT), Etests MBL IP/IPI, MP/MPI, Etests MP/MPB, RDS kit, and the CarbaNP test for screening of carbapenemase producing
Enterobacteriaceae.
MHT
positive
Zn-MHT
positive
Etest KPC MP/MPB number
of isolates
Etest MBL MP/MPI number
of isolates
Etest MBL IP/IPI number
of isolates
RDS Carba NP test
Positive Negative ND Positive Negative ND Positive Negative ND Positive Positive
MBL producers
VIM (n = 19) 16 16 NA NA NA 19 0 0 15 1 4 19 19
NDM (n = 18) 13 17 NA NA NA 18 0 0 17 0 1 18 18
IMP (n = 17) 17 17 NA NA NA 14 1 2 12 0 5 13 17
KPC producers
(n = 48) 48 48 44 2 2 NA NA NA NA NA NA 46 48
Non-carbapenemase producers with reduced susceptibility to carbapenems
(n = 19) 2 4 0 18 1 1 14 4 0 6 13 1 0
Ertapenem-susceptible isolates
(n = 12) 1 1 0 12 0 0 5 7 0 1 11 0 0
SN (%) 91.8 95.1 91.7 94.4 81.5 94.1 100
SP (%) 90.3 83.9 100 97 100 96.7 100
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